U.S. Markets closed

FDA asks for new formulation of Apricus' erectile dysfunction cream

April 16 (Reuters) - Drugmaker Apricus Biosciences Inc said on Monday the U.S. regulator directed it to develop a new formulation for its erectile dysfunction cream, Vitaros, which was rejected in February.

The U.S. Food And Drug Administration also confirmed that two new late-stage studies would need to be conducted to test the reformulated product. (Reporting by Tamara Mathias in Bengaluru; Editing by Anil D'Silva)